• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于注册的射血分数预测算法在心力衰竭患者中的简化:在荷兰心脏病学中心的适用性。

Simplification of a registry-based algorithm for ejection fraction prediction in heart failure patients: Applicability in cardiology centres of the Netherlands.

机构信息

Division Heart and Lungs, Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

出版信息

PLoS One. 2024 Nov 5;19(11):e0310023. doi: 10.1371/journal.pone.0310023. eCollection 2024.

DOI:10.1371/journal.pone.0310023
PMID:39499710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11537407/
Abstract

BACKGROUND

Left ventricular ejection fraction (EF) is used to categorize heart failure (HF) into phenotypes but this information is often missing in electronic health records or non-HF registries.

METHODS

We tested the applicability of a simplified version of a multivariable algorithm, that was developed on data of the Swedish Heart Failure Registry to predict EF in patients with HF. We used data from 4,868 patients with HF from the Cardiology Centers of the Netherlands database, an organization of 13 cardiac outpatient clinics that operate between the general practitioner and the hospital cardiologist. The algorithm included 17 demographical and clinical variables. We tested model discrimination, model performance and calculated model sensitivity, specificity, positive and negative predictive values for EF ≥ vs. <50% and EF ≥ vs. <40%. We additionally performed a multivariable multinomial analysis for all three separate HF phenotypes (with reduced, mildly reduced and preserved EF) HFrEF vs. HFmrEF vs. HFpEF. Finally, we internally validated the model by using temporal validation.

RESULTS

Mean age was 66 ±12 years, 44% of patients were women, 68% had HFpEF, 17% had HFrEF, and 15% had HFmrEF. The C-statistic was of 0.71 for EF ≥/< 50% (95% CI: 0.69-0.72) and of 0.74 (95% CI: 0.73-0.75) for EF ≥/< 40%. The model had the highest sensitivities for EF ≥50% (0.72, 95% CI: 0.63-0.75) and for EF ≥40% (0.70, 95% CI: 0.65-0.71). Similar results were achieved by the multinomial model, but the C-statistics for predicting HFpEF vs HFrEF was lower (0.61, 95% CI 0.58-0.63). The internal validation confirmed good discriminative ability.

CONCLUSIONS

A simple algorithm based on routine clinical characteristics can help discern HF phenotypes in non-cardiology datasets and research settings such as research on primary care data, where measurements of EF is often not available.

摘要

背景

左心室射血分数(EF)用于将心力衰竭(HF)分为表型,但电子健康记录或非 HF 登记处通常缺少此信息。

方法

我们测试了一种简化的多变量算法的适用性,该算法是在瑞典心力衰竭登记处的数据上开发的,用于预测 HF 患者的 EF。我们使用了来自荷兰心脏病学中心数据库的 4868 名 HF 患者的数据,该数据库是由 13 家心脏门诊组成的组织,在全科医生和医院心脏病专家之间运作。该算法包括 17 个人口统计学和临床变量。我们测试了模型的判别能力、性能,并计算了 EF≥与<50%和 EF≥与<40%的模型灵敏度、特异性、阳性和阴性预测值。我们还对所有三种单独的 HF 表型(射血分数降低、轻度降低和保留)进行了多变量多项分析,即射血分数降低性心力衰竭(HFrEF)与射血分数中间值降低性心力衰竭(HFmrEF)与射血分数保留性心力衰竭(HFpEF)。最后,我们通过使用时间验证来对模型进行内部验证。

结果

平均年龄为 66±12 岁,44%的患者为女性,68%为 HFpEF,17%为 HFrEF,15%为 HFmrEF。EF≥/<50%的 C 统计量为 0.71(95%CI:0.69-0.72),EF≥/<40%的 C 统计量为 0.74(95%CI:0.73-0.75)。对于 EF≥50%(0.72,95%CI:0.63-0.75)和 EF≥40%(0.70,95%CI:0.65-0.71),该模型的灵敏度最高。多变量模型也得到了类似的结果,但预测 HFpEF 与 HFrEF 的 C 统计量较低(0.61,95%CI 0.58-0.63)。内部验证证实了该模型具有良好的判别能力。

结论

基于常规临床特征的简单算法可以帮助在非心脏病学数据集和研究环境中识别 HF 表型,例如在初级保健数据研究中,EF 的测量通常不可用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a10/11537407/7cf9cfcfa309/pone.0310023.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a10/11537407/bccaf472f8b2/pone.0310023.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a10/11537407/94dc5ec1fce1/pone.0310023.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a10/11537407/b518a943bfaa/pone.0310023.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a10/11537407/7cf9cfcfa309/pone.0310023.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a10/11537407/bccaf472f8b2/pone.0310023.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a10/11537407/94dc5ec1fce1/pone.0310023.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a10/11537407/b518a943bfaa/pone.0310023.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a10/11537407/7cf9cfcfa309/pone.0310023.g004.jpg

相似文献

1
Simplification of a registry-based algorithm for ejection fraction prediction in heart failure patients: Applicability in cardiology centres of the Netherlands.基于注册的射血分数预测算法在心力衰竭患者中的简化:在荷兰心脏病学中心的适用性。
PLoS One. 2024 Nov 5;19(11):e0310023. doi: 10.1371/journal.pone.0310023. eCollection 2024.
2
A registry-based algorithm to predict ejection fraction in patients with heart failure.基于登记的算法预测心力衰竭患者的射血分数。
ESC Heart Fail. 2020 Oct;7(5):2388-2397. doi: 10.1002/ehf2.12779. Epub 2020 Jun 17.
3
Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.在中国 4880 例队列中,射血分数保留、轻度降低和降低的心衰患者的 5 年死亡率。
ESC Heart Fail. 2022 Aug;9(4):2336-2347. doi: 10.1002/ehf2.13921. Epub 2022 Apr 18.
4
Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.心力衰竭中纵向射血分数变化的流行率和预后意义。
JACC Heart Fail. 2019 Apr;7(4):306-317. doi: 10.1016/j.jchf.2018.11.019. Epub 2019 Mar 6.
5
A comprehensive population-based characterization of heart failure with mid-range ejection fraction.具有中等范围射血分数的心力衰竭的综合人群特征描述。
Eur J Heart Fail. 2017 Dec;19(12):1624-1634. doi: 10.1002/ejhf.945. Epub 2017 Sep 25.
6
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.慢性心力衰竭伴射血分数保留、中间范围和降低患者的流行病学和一年结局:ESC 心力衰竭长期注册研究分析。
Eur J Heart Fail. 2017 Dec;19(12):1574-1585. doi: 10.1002/ejhf.813. Epub 2017 Apr 6.
7
Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum.贫血在射血分数谱心力衰竭中的患病率、相关性及其预后作用。
Int J Cardiol. 2020 Jan 1;298:59-65. doi: 10.1016/j.ijcard.2019.08.049. Epub 2019 Aug 28.
8
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.射血分数保留、中间范围和降低的心衰患者的非心脏性与心脏性死亡率。
J Am Heart Assoc. 2019 Oct 15;8(20):e013441. doi: 10.1161/JAHA.119.013441. Epub 2019 Oct 5.
9
Different relationships between pulse pressure and mortality in heart failure with reduced, mid-range and preserved ejection fraction.不同射血分数心力衰竭患者脉压与死亡率的关系:射血分数降低、中间范围和保留。
Int J Cardiol. 2018 Mar 1;254:203-209. doi: 10.1016/j.ijcard.2017.09.187. Epub 2018 Jan 28.
10
Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction.根据射血分数对急性心力衰竭患者死亡率和再住院率的影响进行分层的糖尿病。
ESC Heart Fail. 2020 Feb;7(1):297-305. doi: 10.1002/ehf2.12538. Epub 2019 Dec 11.

本文引用的文献

1
Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF).心力衰竭药物治疗-惰性、滴定和停药:一项多中心观察性研究(EVOLUTION HF)。
JACC Heart Fail. 2023 Jan;11(1):1-14. doi: 10.1016/j.jchf.2022.08.009. Epub 2022 Sep 7.
2
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.达格列净治疗射血分数轻度降低或保留的心力衰竭。
N Engl J Med. 2022 Sep 22;387(12):1089-1098. doi: 10.1056/NEJMoa2206286. Epub 2022 Aug 27.
3
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
J Am Coll Cardiol. 2022 May 3;79(17):1757-1780. doi: 10.1016/j.jacc.2021.12.011. Epub 2022 Apr 1.
4
Heart failure with mid-range or mildly reduced ejection fraction.射血分数中间值或轻度降低的心力衰竭。
Nat Rev Cardiol. 2022 Feb;19(2):100-116. doi: 10.1038/s41569-021-00605-5. Epub 2021 Sep 6.
5
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净治疗射血分数保留的心力衰竭。
N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27.
6
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
7
Routine clinical care data from thirteen cardiac outpatient clinics: design of the Cardiology Centers of the Netherlands (CCN) database.来自十三个心脏门诊的常规临床护理数据:荷兰心脏病学中心(CCN)数据库的设计。
BMC Cardiovasc Disord. 2021 Jun 10;21(1):287. doi: 10.1186/s12872-021-02020-7.
8
External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure.基于索赔数据的预测心力衰竭患者左心室射血分数模型的外部验证。
PLoS One. 2021 Jun 4;16(6):e0252903. doi: 10.1371/journal.pone.0252903. eCollection 2021.
9
Epidemiology and pathogenesis of heart failure with preserved ejection fraction.射血分数保留型心力衰竭的流行病学和发病机制。
Rev Cardiovasc Med. 2020 Dec 30;21(4):531-540. doi: 10.31083/j.rcm.2020.04.154.
10
A registry-based algorithm to predict ejection fraction in patients with heart failure.基于登记的算法预测心力衰竭患者的射血分数。
ESC Heart Fail. 2020 Oct;7(5):2388-2397. doi: 10.1002/ehf2.12779. Epub 2020 Jun 17.